# Phase I Trial of Smallpox Vaccine

> **NCT00046397** · PHASE1 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 195 (—)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Modified Vaccinia Virus Ankara TBC-M

## Key facts

- **NCT ID:** NCT00046397
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-09
- **Primary completion:** —
- **Final completion:** 2005-08
- **Target enrollment:** 195 (—)
- **Last updated:** 2008-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00046397

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00046397, "Phase I Trial of Smallpox Vaccine". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00046397. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*